<code id='787F46E27A'></code><style id='787F46E27A'></style>
    • <acronym id='787F46E27A'></acronym>
      <center id='787F46E27A'><center id='787F46E27A'><tfoot id='787F46E27A'></tfoot></center><abbr id='787F46E27A'><dir id='787F46E27A'><tfoot id='787F46E27A'></tfoot><noframes id='787F46E27A'>

    • <optgroup id='787F46E27A'><strike id='787F46E27A'><sup id='787F46E27A'></sup></strike><code id='787F46E27A'></code></optgroup>
        1. <b id='787F46E27A'><label id='787F46E27A'><select id='787F46E27A'><dt id='787F46E27A'><span id='787F46E27A'></span></dt></select></label></b><u id='787F46E27A'></u>
          <i id='787F46E27A'><strike id='787F46E27A'><tt id='787F46E27A'><pre id='787F46E27A'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:359
          STR/AFP via Getty Images

          A traditional Chinese medicine compound used for cardiac benefits might help reduce the incidence of major adverse cardiac and cerebrovascular events and even cardiac death rates, according to a new study published Tuesday in the Journal of the American Medical Association.

          However, some outside experts expressed skepticism about the result.

          advertisement

          Tongxinluo — which means “to open (tong) the network (luo) of the heart (xin)” in Mandarin —  is a traditional Chinese medicine compound made out of a mixture of powders and extracts from plants, centipedes, cicadas, and other sources.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Readout Newsletter: BridgeBio, Akero, and human embryo models
          Readout Newsletter: BridgeBio, Akero, and human embryo models

          WellcomeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletteri

          read more
          Moonlake's readout produced a cash windfall. Risks remain
          Moonlake's readout produced a cash windfall. Risks remain

          MollyFerguson/STATFortwodaysstartingonSunday,MoonlakeImmunotherapeuticshappilycrunchednumbersandshar

          read more

          $1 billion proposal to grow Boston, Massachusetts biotech

          AscientistworkingatSQZBiotechnologiesinWatertown,Mass.DavidLRyan/GlobeStaffNextstop:BeaconHill.Gover